Guangxi LiuYao Group Co., Ltd (603368.SS)
CNY 18.49
(-0.59%)
CNY 18.49
(-0.59%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 20.81 Billion CNY | 9.23% |
| 2022 | 19.05 Billion CNY | 11.19% |
| 2021 | 17.13 Billion CNY | 9.36% |
| 2020 | 15.66 Billion CNY | 5.46% |
| 2019 | 14.85 Billion CNY | 26.82% |
| 2018 | 11.71 Billion CNY | 24.0% |
| 2017 | 9.44 Billion CNY | 24.97% |
| 2016 | 7.55 Billion CNY | 16.16% |
| 2015 | 6.5 Billion CNY | 15.07% |
| 2014 | 5.65 Billion CNY | 24.35% |
| 2013 | 4.54 Billion CNY | 27.82% |
| 2012 | 3.55 Billion CNY | 30.42% |
| 2011 | 2.72 Billion CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 4.86 Billion CNY | -15.71% |
| 2024 Q3 | 5.33 Billion CNY | 9.94% |
| 2024 Q1 | 5.77 Billion CNY | 11.15% |
| 2023 Q3 | 5.27 Billion CNY | 5.26% |
| 2023 Q1 | 5.33 Billion CNY | 10.44% |
| 2023 Q2 | 5 Billion CNY | -6.1% |
| 2023 Q4 | 5.19 Billion CNY | -1.47% |
| 2023 FY | 20.81 Billion CNY | 9.23% |
| 2022 Q3 | 5.02 Billion CNY | 14.42% |
| 2022 Q1 | 4.81 Billion CNY | 13.11% |
| 2022 FY | 19.05 Billion CNY | 11.19% |
| 2022 Q4 | 4.83 Billion CNY | -3.79% |
| 2022 Q2 | 4.38 Billion CNY | -8.84% |
| 2021 Q3 | 4.55 Billion CNY | 9.48% |
| 2021 Q1 | 4.16 Billion CNY | 6.32% |
| 2021 FY | 17.13 Billion CNY | 9.36% |
| 2021 Q2 | 4.16 Billion CNY | -0.0% |
| 2021 Q4 | 4.25 Billion CNY | -6.59% |
| 2020 Q3 | 4.18 Billion CNY | 5.66% |
| 2020 Q4 | 3.91 Billion CNY | -6.39% |
| 2020 FY | 15.66 Billion CNY | 5.46% |
| 2020 Q1 | 3.61 Billion CNY | -3.55% |
| 2020 Q2 | 3.95 Billion CNY | 9.45% |
| 2019 Q3 | 3.91 Billion CNY | 2.65% |
| 2019 Q2 | 3.81 Billion CNY | 12.52% |
| 2019 Q1 | 3.38 Billion CNY | 12.72% |
| 2019 FY | 14.85 Billion CNY | 26.82% |
| 2019 Q4 | 3.74 Billion CNY | -4.16% |
| 2018 Q4 | 3 Billion CNY | -5.93% |
| 2018 Q3 | 3.19 Billion CNY | 13.88% |
| 2018 FY | 11.71 Billion CNY | 24.0% |
| 2018 Q2 | 2.8 Billion CNY | 3.43% |
| 2018 Q1 | 2.71 Billion CNY | 11.93% |
| 2017 Q2 | 2.27 Billion CNY | 5.33% |
| 2017 Q4 | 2.42 Billion CNY | -6.16% |
| 2017 FY | 9.44 Billion CNY | 24.97% |
| 2017 Q1 | 2.16 Billion CNY | 12.7% |
| 2017 Q3 | 2.58 Billion CNY | 13.28% |
| 2016 Q3 | 1.95 Billion CNY | 4.27% |
| 2016 FY | 7.55 Billion CNY | 16.16% |
| 2016 Q4 | 1.91 Billion CNY | -1.85% |
| 2016 Q2 | 1.87 Billion CNY | 3.8% |
| 2016 Q1 | 1.8 Billion CNY | 10.75% |
| 2015 Q3 | 1.73 Billion CNY | 4.16% |
| 2015 FY | 6.5 Billion CNY | 15.07% |
| 2015 Q1 | 1.47 Billion CNY | 4.42% |
| 2015 Q2 | 1.66 Billion CNY | 12.52% |
| 2015 Q4 | 1.63 Billion CNY | -5.84% |
| 2014 Q3 | 1.48 Billion CNY | 1.44% |
| 2014 Q4 | 1.41 Billion CNY | -4.6% |
| 2014 FY | 5.65 Billion CNY | 24.35% |
| 2014 Q2 | 1.46 Billion CNY | 13.33% |
| 2014 Q1 | 1.29 Billion CNY | 7.78% |
| 2013 Q3 | 1.24 Billion CNY | 0.0% |
| 2013 FY | 4.54 Billion CNY | 27.82% |
| 2013 Q4 | 1.19 Billion CNY | -3.4% |
| 2012 FY | 3.55 Billion CNY | 30.42% |
| 2011 FY | 2.72 Billion CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| China Meheco Group Co., Ltd. | 38.82 Billion CNY | 46.395% |
| Liaoning Cheng Da Co., Ltd. | 10.78 Billion CNY | -93.01% |
| Shanghai Pharmaceuticals Holding Co., Ltd | 260.29 Billion CNY | 92.004% |